OSE Immunotherapeutics SA

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
Rok finansowy 2012 2012 2013 2013 2013 2013 2014 2014 2015 2015 2016 2016 2017 2017 2018 2018 2019 2019 2020 2020 2021 2021 2022 2022 2023 2023 2024 2024
Kwartał Q2 Q4 Q1 Q2 Q3 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4
Data 2012-06-30 2012-12-31 2013-03-31 2013-06-30 2013-09-30 2013-12-31 2014-06-30 2014-12-31 2015-06-30 2015-12-31 2016-06-30 2016-12-31 2017-06-30 2017-12-31 2018-06-30 2018-12-31 2019-06-30 2019-12-31 2020-06-30 2020-12-31 2021-06-30 2021-12-31 2022-06-30 2022-12-31 2023-06-30 2023-12-31 2024-06-30 2024-12-31
Przychód (mln) 0 0 0 0 0 0 0 0 0 0 0 0 3 4 21 4 16 10 6 5 9 17 16 2 1 1 69 1
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% inf% inf% inf% inf% 284800.0% 127666.7% 52741.0% 1018.6% 460.9% 160.2% -71.62% 18.7% -43.83% 73.8% 174.4% -50.65% -84.87% -94.99% 330.3% -63.15%
Marża brutto 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0%
Koszty i Wydatki (mln) 1 1 -0 0 -0 0 1 2 3 3 22 5 10 9 10 9 15 16 13 16 24 24 23 20 21 11 23 20
EBIT (mln) -1 -1 -0 -0 -0 -0 -1 -2 -3 -3 4 -5 -7 -5 10 -6 1 -6 -7 -12 -15 -7 -7 -17 -19 -9 46 -20
EBIT Δ kw/kw 0.0% 0.0% 0.0% 0.0% -91.14% -82.28% 972.1% 1671.3% 4273.4% 1947.7% 745.9% 121.7% 162.1% 101.8% 145.2% 15.0% 119.5% 22.8% -168.42% 116.3% -1138.70% 9.0% -4.49% 44.8% 28.9% 34.0% 781.5% 13.5%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -279900.00% -87366.67% 10830.8% -1392.73% -257.49% -137.99% 50.3% -143.19% 9.0% -65.13% -121.15% -260.82% -165.96% -40.84% -42.18% -765.14% -1414.06% -1091.02% 66.8% -2356.92%
Przychody fiansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 1
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 2 1
Amortyzacja (mln) -1 -1 -0 0 -0 0 1 2 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 2 2 0 2 2
EBITDA (mln) -1 -1 -0 -0 -0 0 -0 -0 0 0 4 -5 -9 -7 8 -7 2 -6 -7 -12 -13 -5 -3 -16 -12 -12 61 -18
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -278900.00% -84400.00% 10889.7% -1368.31% -254.55% -136.97% 50.5% -141.74% 10.4% -62.50% -118.89% -257.43% -156.56% -30.75% -31.77% -686.47% -1279.46% -1071.23% 87.8% -2192.66%
NOPLAT (mln) -1 -1 -0 -0 -0 -0 -1 -2 -3 -3 22 -5 -7 -5 10 -5 2 -6 -7 -12 -14 -7 -5 -18 -14 -11 57 -21
Podatek (mln) 1 1 -0 -0 0 0 -0 0 0 0 2 1 1 1 1 2 1 -1 -4 1 -3 -2 -3 -3 -3 0 -0 -1
Zysk Netto (mln) -1 -1 -0 -0 -0 -0 -1 -2 -3 -3 25 -4 -6 -4 9 -3 1 -5 -3 -13 -11 -5 -2 -16 -12 -11 57 -20
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% -91.16% -82.31% 965.0% 1672.4% 4533.1% 1980.3% 3841.4% 76.1% 115.5% 57.6% -63.78% -11.80% 108.1% 24.1% -135.08% 296.8% -2335.02% 3.8% -36.45% 17.4% 3.2% 107.8% 2989.1% 25.0%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -294200.00% -88066.67% 62835.9% -1116.28% -222.53% -108.61% 43.1% -88.02% 3.2% -51.80% -53.24% -294.18% -128.00% -30.94% -12.33% -699.82% -873.34% -1282.28% 82.8% -2374.25%
EPS -0.09 -0.09 -0.0081 -0.02 -0.0083 -0.0166 -0.09 -0.27 -0.32 -0.27 2.1 -0.25 -0.44 -0.29 0.57 -0.23 0.0347 -0.35 -0.21 -0.84 -0.64 -0.29 -0.11 -0.86 -0.64 -0.54 2.63 -0.91
EPS (rozwodnione) -0.09 -0.09 -0.0081 -0.0161 -0.0083 -0.0166 -0.0858 -0.27 -0.32 -0.26 2.1 -0.25 -0.44 -0.29 0.57 -0.22 0.032 -0.35 -0.21 -0.84 -0.64 -0.29 -0.11 -0.86 -0.64 -0.54 2.63 -0.91
Ilośc akcji (mln) 8 8 8 6 8 8 7 8 9 10 12 15 14 14 16 15 15 15 15 16 18 18 18 18 19 20 22 22
Ważona ilośc akcji (mln) 8 8 8 8 8 8 8 8 9 10 12 15 14 14 16 16 16 15 15 16 18 18 18 18 19 20 22 22
Waluta EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR